Gynecological cancers refer to cancers that specifically affect the female reproductive system, including the cervix, ovaries, uterus, fallopian tubes, vagina and vulva. These types of cancers can have a significant impact on a woman's health and well-being. Alfa Cytology is a world leader in the research of cancer. With our extensive experience and advanced platform, we can provide the best solutions for gynecologic cancer.
Introduction to Gynecologic Cancer
It is critical to study the different types, risk factors, symptoms, diagnosis, and available therapy options for gynecological cancers. The exact cause of gynecologic cancer is often unknown, but some risk factors have been identified, as the following graph shows.
Fig.1 Different risk factors associated with gynecological cancer. (Keyvani, V., et al., 2023)
Therapy for Gynecologic Cancer
Prevention and early detection play a vital role in gynecological cancers. It is important to follow the HPV vaccination schedule, get regular screenings, and maintain a healthy lifestyle to prevent gynecological cancers. Therapy options vary depending on the specific type, stage, and individual situation, but may include these.
- Hormone Therapy
- Combination of Therapies
Through the continuous development of bioengineering methods, several companies focus on gynecological cancer drugs and therapy development.
- Roche has developed drugs such as Avastin (bevacizumab), which is used in cervical, ovarian, and fallopian tube cancers.
- Tesaro, Inc. has developed Zejula (niraparib), an oral PARP inhibitor approved for ovarian cancer, fallopian tube cancer, and peritoneal cancer.
Our Services
The process of diagnosing and treating gynecological cancer can be extremely stressful both physically and emotionally. Therefore, Alfa Cytology is working on providing one-stop solutions for gynecologic cancer, including but not limited to the following.
Alfa Cytology is committed to the research and study of cancer, from molecular biology services, and cancer biomarker discovery services, to preclinical research services, providing one-stop services. Our cancer experts have many years of experience in the development of the latest therapies for gynecologic cancer. If you are interested in our service, please contact us.
Reference
- Keyvani, V., et al.; (2023). Epidemiological trends and risk factors of gynecological cancers: an update. Medical Oncology, 40(3), 93.
For research use only.
Related Services
